EquityLK
All analyses
AI analysis

HNB Life PLC: research report

HASUView stock page →
Moderately undervaluedbullishAug 7, 2026

HNB Life is growing fast and still priced low: Q2 net profit rose 47.9% y/y while the stock trades at 9.6x earnings. The catch is thin margins.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bullish

  • It trades at 9.62x earnings versus a sector median 15.5x, with ROE of 16.9%
  • Operational momentum is firm, with Q2 net profit up 47.9% y/y on 23.9% revenue growth

Against this. Latest quarterly net margin was 3.5%, among its worst within June quarters (6 of 7), showing limited cushion.

Operating margin
3.8%
of revenue plus other operating income, which is larger than revenue here
Net margin
2.8%
of revenue plus other operating income; profit here is mostly not from revenue
Return on equity
18.6%
twelve months to Jun 30, 2026, unaudited
P/E
8.6sector 13.1
earnings Rs 16.39 per share
P/B
1.60sector 1.52
book Rs 88.10 per share
Dividend yield
3.55%sector 1.78%
30.5% of earnings paid out

Current figures, updated daily from filings to Jun 30, 2026. The report below was written on Aug 7, 2026. Sector figures are the median of 11 listed companies in the same sector.

Overview

HNB Life PLC is a Sri Lankan multi-line insurer with life and general operations (HNBGI), distributing through agency, bancassurance and alternate channels. The story right now is profitable growth on a stronger capital base while keeping leverage low, set against still-thin quarterly margins.

Price performance

The share closed at LKR 151 as of 2026-08-07. It outperformed the market over longer windows, up 34.2% in 6 months versus the ASPI’s -10.6%, and 42.7% over 1 year versus 9.5%. The price sits near its 52-week high of LKR 153, with gains concentrated in recent months.

Valuation

At 9.62x earnings, the share is priced below the insurance sector’s 15.5x median, while its 1.71x book is fuller but supported by a 16.9% ROE. The cash return is modest for the sector, but the payout is progressing: DPS rose to LKR 5.00 for FY2025 from LKR 3.90 in FY2024 and FY2023.

News and sentiment

Coverage is normal with 5 material articles in the last 90 days, skewing positive (3 positive, 0 negative). HNB Life reported Q1 FY2026 gross written premium growth of 54% y/y, and HNBGI added experienced directors and a new COO. A first and final LKR 5.00 dividend for FY2025 was confirmed, ex 2026-03-31 and paid 2026-04-23.

Financials

June-quarter operating margin widened from 4.2% to 4.8%, and net margin rose from 3.0% to 3.5%. Revenue grew 23.9% y/y, while the below-the-line items remained a drag of LKR 117 million. Within the company’s own record this was still a weak profitability print for a June quarter, even as absolute profits improved.

For context, FY2025 delivered double-digit growth with a healthy return profile, but the latest quarter shows the task is to translate top line momentum into sturdier margins.

Risks

The lead risk is earnings sensitivity to thin profitability: net margin was 3.5% in the latest quarter and below-the-line charges of LKR 117 million continue to take a material slice of operating profit. Balance sheet risk is low but not absent, with gearing at 6.6% of equity and interest cover a comfortable 14.8x. Sector returns are tied to investment yields that sit around the low double-digits as at early August (about 11%), so a sustained drift lower would test investment income.

Outlook

As at 2026-08-07, the next filing for the quarter to 2026-09-30 is expected between 2026-10-28 and 2027-01-26. Into that print, the swing factor is whether margins lift from a historically weak June-quarter rank while maintaining the recent revenue growth cadence. With bond yields easing, watch how investment income and fair-value movements flow through reported profit.

About this report. Generated on Aug 7, 2026 from market data up to Aug 7, 2026, 5 material news articles over 90 days and financials to Jun 30, 2026. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.